Madison Covered Call & Equity Income Fund Class R6
MENRX
NASDAQ
| Weiss Ratings | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Madison Funds | |||
| Manager/Tenure (Years) | Ray DiBernardo (15), Drew Justman (8) | |||
| Website | http://www.madisonfunds.com | |||
| Fund Information | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Madison Covered Call & Equity Income Fund Class R6 | |||
| Category | Derivative Income | |||
| Sub-Category | Equity Miscellaneous | |||
| Prospectus Objective | Equity-Income | |||
| Inception Date | Jul 31, 2012 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 500,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 7.98% | |||
| Dividend | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.71% | |||
| Asset Allocation | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 16.40% | |||
| Stock | 83.60% | |||
| U.S. Stock | 77.81% | |||
| Non-U.S. Stock | 5.79% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.53% | |||
| 30-Day Total Return | 2.99% | |||
| 60-Day Total Return | 4.50% | |||
| 90-Day Total Return | 0.85% | |||
| Year to Date Total Return | -1.87% | |||
| 1-Year Total Return | -0.64% | |||
| 2-Year Total Return | 6.16% | |||
| 3-Year Total Return | 14.06% | |||
| 5-Year Total Return | 65.92% | |||
| Price | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $9.28 | |||
| 1-Month Low NAV | $8.97 | |||
| 1-Month High NAV | $9.39 | |||
| 52-Week Low NAV | $8.22 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $10.33 | |||
| 52-Week High Price (Date) | Sep 27, 2024 | |||
| Beta / Standard Deviation | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.55 | |||
| Standard Deviation | 11.45 | |||
| Balance Sheet | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 202.07M | |||
| Operating Ratios | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.91% | |||
| Turnover Ratio | 144.00% | |||
| Performance | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.54% | |||
| Last Bear Market Total Return | -8.45% | |||